Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Passage Bio Inc
(NQ:
PASG
)
0.9550
-0.0550 (-5.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Passage Bio Inc
< Previous
1
2
3
4
Next >
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors
July 31, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio And 2 Other Penny Stocks Insiders Are Aggressively Buying
June 30, 2023
The Dow Jones closed higher by over 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 15, 2023
On Thursday, 64 companies achieved new lows for the year.
Via
Benzinga
Recap: Passage Bio Q1 Earnings
May 11, 2023
Via
Benzinga
Passage Bio's Earnings: A Preview
March 03, 2023
Via
Benzinga
Expert Ratings for Passage Bio
December 15, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 14, 2023
On Wednesday, 33 stocks hit new 52-week lows.
Via
Benzinga
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
May 11, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Stock Jumps After Gene Therapy Study In Lysosomal Storage Disorder
December 14, 2022
Via
Benzinga
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 21, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 17, 2023
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
On Monday, 89 stocks made new 52-week lows.
Via
Benzinga
Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
March 27, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights
March 06, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023
February 27, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023
February 24, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present Updated Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023
February 15, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2023
From
Passage Bio
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 15, 2022
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 14, 2022
Via
Benzinga
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
December 14, 2022
From
Passage Bio
Via
GlobeNewswire
Passage Bio Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 10, 2022
From
Passage Bio
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Upgrades
Via
Benzinga
Passage Bio to Present at Guggenheim 4th Annual Immunology & Neurology Day
November 08, 2022
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Report Third Quarter 2022 Financial Results on November 10, 2022
November 03, 2022
From
Passage Bio
Via
GlobeNewswire
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 14, 2022
From
Passage Bio
Via
GlobeNewswire
Passage Bio Announces Appointment of William Chou, M.D. as Chief Executive Officer
October 10, 2022
From
Passage Bio
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.